603379.SS
Zhejiang Sanmei Chemical Industry Co., Ltd. [603379.SS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
603379.SS Stock Summary
In the News
603379.SS Financial details
Company Rating
Strong Buy
Market Cap
26.06B
Income
261.88M
Revenue
3.61B
Book val./share
9.62
Cash/share
5.74
Dividend
0.24
Dividend %
0.72%
Employees
1.87K
Optionable
No
Shortable
Yes
Earnings
30 Apr 2024
P/E
75.39
Forward P/E
-
PEG
-14.82
P/S
5.58
P/B
3.37
P/C
7.55
P/FCF
-44.14
Quick Ratio
5.8
Current Ratio
6.42
Debt / Equity
0
LT Debt / Equity
0
-
-
EPS (TTM)
0.43
EPS next Y
-
EPS next Q
-
EPS this Y
-9.09%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-17.55%
Revenue last 5Y
1.38%
Revenue Q/Q
-8.97%
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
30.3%
SMA100
53.57%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
5%
ROC
0.06%
Gross Margin
12%
Oper. Margin
10%
Profit Margin
7%
Payout
56%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
22.44-47.15
52W High
-7.83%
52W Low
+96.91%
RSI
53
Rel Volume
0.59
Avg Volume
7.81M
Volume
4.59M
Perf Week
3.59%
Perf Month
-0.09%
Perf Quarter
72.32%
Perf Half Y
59.32%
-
-
-
-
Beta
0.553
-
-
Volatility
0.7%, 1.33%
Prev Close
-0.64%
Price
43.32
Change
-2.65%
603379.SS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 8.44 | 6.45 | 4.46 | 6.64 | 7.86 | |
| Net income per share | 2.1 | 1.06 | 0.36 | 0.88 | 0.8 | |
| Operating cash flow per share | 2.3 | 1.08 | 0.85 | 0.4 | 1.04 | |
| Free cash flow per share | 1.98 | 0.83 | 0.69 | 0.17 | 0.33 | |
| Cash per share | 1.53 | 5.23 | 5.66 | 5.62 | 5.98 | |
| Book value per share | 4.72 | 8.11 | 8.16 | 8.68 | 9.41 | |
| Tangible book value per share | 4.58 | 7.95 | 7.96 | 8.39 | 9.01 | |
| Share holders equity per share | 4.72 | 8.11 | 8.16 | 8.68 | 9.41 | |
| Interest debt per share | 0.8 | -0.06 | 0 | 0 | 0 | |
| Market cap | 22.28B | 16.29B | 11.66B | 13.88B | 17.27B | |
| Enterprise value | 21.83B | 14.54B | 9.17B | 12.27B | 13.77B | |
| P/E ratio | 20.12 | 25.22 | 52.56 | 25.89 | 35.57 | |
| Price to sales ratio | 5 | 4.14 | 4.29 | 3.43 | 3.62 | |
| POCF ratio | 18.33 | 24.69 | 22.43 | 57 | 27.47 | |
| PFCF ratio | 21.38 | 32.24 | 27.68 | 137.65 | 86.36 | |
| P/B Ratio | 8.96 | 3.29 | 2.34 | 2.62 | 3.03 | |
| PTB ratio | 8.96 | 3.29 | 2.34 | 2.62 | 3.03 | |
| EV to sales | 4.9 | 3.69 | 3.37 | 3.03 | 2.89 | |
| Enterprise value over EBITDA | 14.35 | 15.23 | 24.94 | 14.3 | 17.86 | |
| EV to operating cash flow | 17.96 | 22.03 | 17.65 | 50.38 | 21.91 | |
| EV to free cash flow | 20.95 | 28.77 | 21.78 | 121.66 | 68.86 | |
| Earnings yield | 0.05 | 0.04 | 0.02 | 0.04 | 0.03 | |
| Free cash flow yield | 0.05 | 0.03 | 0.04 | 0.01 | 0.01 | |
| Debt to equity | 0.16 | -0.01 | 0 | 0 | 0 | |
| Debt to assets | 0.11 | -0.01 | 0 | 0 | 0 | |
| Net debt to EBITDA | -0.29 | -1.83 | -6.75 | -1.88 | -4.54 | |
| Current ratio | 2.38 | 11.24 | 11.81 | 6.52 | 6.75 | |
| Interest coverage | 71.41 | 148.63 | 871.51 | 2.44K | 2.06K | |
| Income quality | 1.1 | 1.02 | 2.35 | 0.45 | 1.29 | |
| Dividend Yield | 0.02 | 0 | 0.02 | 0 | 0.01 | |
| Payout ratio | 0.36 | 0.1 | 0.88 | 0.13 | 0.21 | |
| Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | |
| Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.03 | 0.04 | |
| Capex to operating cash flow | -0.14 | -0.23 | -0.19 | -0.59 | -0.68 | |
| Capex to revenue | -0.04 | -0.04 | -0.04 | -0.04 | -0.09 | |
| Capex to depreciation | -2.64 | -1.76 | -1.03 | -1.46 | -4.2 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0.01 | |
| Graham number | 14.93 | 13.9 | 8.17 | 13.11 | 13.01 | |
| ROIC | 0.38 | 0.13 | 0.04 | 0.1 | 0.09 | |
| Return on tangible assets | 0.32 | 0.12 | 0.04 | 0.09 | 0.08 | |
| Graham Net | 0.88 | 5.67 | 5.81 | 5.86 | 5.9 | |
| Working capital | 1.39B | 3.81B | 3.84B | 4.08B | 4.03B | |
| Tangible asset value | 2.42B | 4.85B | 4.86B | 5.11B | 5.47B | |
| Net current asset value | 1.37B | 3.78B | 3.81B | 4.05B | 4.01B | |
| Invested capital | 0.16 | -0.01 | 0 | 0 | 0 | |
| Average receivables | 767.19M | 705.11M | 581.8M | 657.72M | 703.09M | |
| Average payables | 111.67M | 122.6M | 96.71M | 210.48M | 331.41M | |
| Average inventory | 304.94M | 306.36M | 270.25M | 392.67M | 525.09M | |
| Days sales outstanding | 56.19 | 67.21 | 58.9 | 79.01 | 40.54 | |
| Days payables outstanding | 19.1 | 13.79 | 14.06 | 38.96 | 30.16 | |
| Days of inventory on hand | 48.12 | 34.08 | 44.65 | 59.01 | 49.89 | |
| Receivables turnover | 6.5 | 5.43 | 6.2 | 4.62 | 9 | |
| Payables turnover | 19.11 | 26.46 | 25.95 | 9.37 | 12.1 | |
| Inventory turnover | 7.59 | 10.71 | 8.17 | 6.19 | 7.32 | |
| ROE | 0.45 | 0.13 | 0.04 | 0.1 | 0.09 | |
| Capex per share | -0.33 | -0.25 | -0.16 | -0.23 | -0.71 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 1.99 | 1.64 | 1.29 | 1.58 | 1.43 | |
| Net income per share | 0.2 | 0.04 | 0.03 | 0.18 | 0.18 | |
| Operating cash flow per share | 0.2 | 0.04 | 0.03 | 0.34 | 0 | |
| Free cash flow per share | 0.07 | -0.26 | -0.24 | 0.09 | -0.34 | |
| Cash per share | 6.34 | 5.95 | 6.12 | 6.01 | 5.74 | |
| Book value per share | 9.42 | 9.35 | 9.5 | 9.42 | 9.62 | |
| Tangible book value per share | 9.01 | 8.96 | 9.04 | 8.96 | 9.13 | |
| Share holders equity per share | 9.42 | 9.35 | 9.5 | 9.42 | 9.62 | |
| Interest debt per share | 0 | 0 | 0.01 | 0 | 0 | |
| Market cap | 13.68B | 17.37B | 20.27B | 14.31B | 17.47B | |
| Enterprise value | 10.28B | 13.87B | 16.65B | 10.72B | 14.04B | |
| P/E ratio | 29.06 | 182.16 | 253.76 | 32.59 | 40.32 | |
| Price to sales ratio | 11.41 | 17.33 | 26.07 | 14.92 | 20.02 | |
| POCF ratio | 116.26 | 728.64 | 1.02K | 69.46 | -7.85K | |
| PFCF ratio | 315.11 | -107.85 | -139.76 | 257.35 | -84.67 | |
| P/B Ratio | 2.41 | 3.04 | 3.53 | 2.5 | 2.99 | |
| PTB ratio | 2.41 | 3.04 | 3.53 | 2.5 | 2.99 | |
| EV to sales | 8.58 | 13.84 | 21.41 | 11.18 | 16.09 | |
| Enterprise value over EBITDA | 98.44 | 251.55 | 1.51K | 71.12 | 96.9 | |
| EV to operating cash flow | 87.38 | 581.83 | 833.48 | 52.04 | -6.31K | |
| EV to free cash flow | 236.83 | -86.12 | -114.76 | 192.8 | -68.07 | |
| Earnings yield | 0.01 | 0 | 0 | 0.01 | 0.01 | |
| Free cash flow yield | 0 | -0.01 | -0.01 | 0 | -0.01 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | -32.54 | -63.47 | -328.62 | -23.81 | -23.63 | |
| Current ratio | 6.98 | 6.75 | 8.52 | 6.2 | 6.42 | |
| Interest coverage | -606.9 | 476.93 | 7.07 | 1.44K | 8.64K | |
| Income quality | 1 | 1 | 1 | 1.88 | -0.02 | |
| Dividend Yield | 0 | 0 | 0 | 0.01 | 0 | |
| Payout ratio | 0 | 0 | 0 | 1.33 | 0 | |
| Sales general and administrative to revenue | 0.07 | -0.04 | 0.05 | -0.01 | 0.09 | |
| Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | |
| Intangibles to total assets | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 | |
| Capex to operating cash flow | -0.63 | -7.76 | -8.26 | -0.73 | 91.66 | |
| Capex to revenue | -0.06 | -0.18 | -0.21 | -0.16 | -0.23 | |
| Capex to depreciation | -2.63 | -6.55 | -5.94 | -5.41 | 3.95 | |
| Stock based compensation to revenue | -0.01 | 0.01 | 0 | 0.01 | -0.01 | |
| Graham number | 6.43 | 2.87 | 2.66 | 6.18 | 6.21 | |
| ROIC | 0.01 | 0 | 0 | 0.02 | 0.02 | |
| Return on tangible assets | 0.02 | 0 | 0 | 0.02 | 0.02 | |
| Graham Net | 6.35 | 5.87 | 6.03 | 5.71 | 5.6 | |
| Working capital | 4.28B | 4.03B | 3.99B | 3.85B | 3.8B | |
| Tangible asset value | 5.43B | 5.47B | 5.46B | 5.46B | 5.55B | |
| Net current asset value | 4.26B | 4.01B | 3.98B | 3.84B | 3.78B | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 724.11M | 607.93M | 443.5M | 421.11M | 528.86M | |
| Average payables | 290.5M | 334.58M | 262.2M | 244.41M | 383.23M | |
| Average inventory | 452.46M | 500.43M | 502.51M | 444.52M | 414.59M | |
| Days sales outstanding | 51.48 | 47.56 | 41.34 | 45.53 | 59.06 | |
| Days payables outstanding | 28.15 | 33.37 | 24.93 | 32.18 | 55.77 | |
| Days of inventory on hand | 37.74 | 55.21 | 58.95 | 47.01 | 47.09 | |
| Receivables turnover | 1.75 | 1.89 | 2.18 | 1.98 | 1.52 | |
| Payables turnover | 3.2 | 2.7 | 3.61 | 2.8 | 1.61 | |
| Inventory turnover | 2.38 | 1.63 | 1.53 | 1.91 | 1.91 | |
| ROE | 0.02 | 0 | 0 | 0.02 | 0.02 | |
| Capex per share | -0.12 | -0.3 | -0.27 | -0.25 | -0.34 |
603379.SS Frequently Asked Questions
What is Zhejiang Sanmei Chemical Industry Co., Ltd. stock symbol ?
Zhejiang Sanmei Chemical Industry Co., Ltd. is a CN stock and trading under the symbol 603379.SS
What is Zhejiang Sanmei Chemical Industry Co., Ltd. stock quote today ?
Zhejiang Sanmei Chemical Industry Co., Ltd. stock price is $43.32 today.
Is Zhejiang Sanmei Chemical Industry Co., Ltd. stock public?
Yes, Zhejiang Sanmei Chemical Industry Co., Ltd. is a publicly traded company.
Company Profile
- Volume Average 7.81M
- Market Capitalization 26.06B
- Employee 1.87K
- CEO Mr. Qixiang Hu
- Headquarters Jinhua,CN
- IPO Date 2019-04-09
-
Website
https://www.sanmeichem.com 
Zhejiang Sanmei Chemical Industry Co., Ltd. engages in the research and development, production, and sales of fluorochemical products. It offers foaming agents/hydrofluoric acid, fluorinated refrigerant, ODS substitute products, fluoride salt, hydrochloric acid, and calcium sulfate. The company is based in Jinhua, China.
